An in-depth look to META BIOMED.CO.,LTD operating, investing, and financing activities

059210 free cash flow for Q3 24 is 2.92 B KRW. For 2023, 059210 free cash flow was -1.27 B KRW and operating cash flow was 10.22 B KRW.